{"name":"invoX Pharma Limited","slug":"invox-pharma-limited","ticker":"","exchange":"","domain":"","description":"invoX Pharma Limited is a biopharmaceutical company focused on the development of innovative therapies. The company has a pipeline of four drugs, all currently in early stages of clinical development, with a focus on advancing treatments for various diseases.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FS120","genericName":"FS120","slug":"fs120","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"FS120","genericName":"FS120","slug":"fs120","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOSmtraW5IQWR1dmhvXzlGUmM3Vm9GOEgwcnE0M0JZRnBES0t5a1BKd0cwZTNoSmlFS0Qza2dtNDlqc2dKQ2xMMFYtMmRvUG1TWTdqenZHWjdFYXJZYXZ4dm1hVENuZzhuRWpURGNvTE1JaEtyZnBPcGZyQjFmRTVzZ1kwVEZWVjhkTU1hcnJCbjhIUEc0QXdjN25teTVuV2ViWVc3Y3E4Nno?oc=5","date":"2025-04-04","type":"pipeline","source":"Fierce Biotech","summary":"F-star charts new path, splitting from invoX after 2023's $161M acquisition - Fierce Biotech","headline":"F-star charts new path, splitting from invoX after 2023's $161M acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNZW5ZOHB0RkRPZi1DRjhGTm9FZjdiMGp5LVBMenRwVWs0TkZaZFdVX2toSlpvR3V3UHpqWWFxWmx1dmtMdWdkdE5EWVVWTURKbmFVTVZTTFI2WlBDV0M1dUo5TnRsWDVKVXRkdEFyWVJ4Y3dpZV8wcGR6WElrWFVMbEhfMDNBWmktRkxjOWtuaWhocTJkQmllOWMxM2JhSHhwMDZN?oc=5","date":"2024-06-04","type":"pipeline","source":"PharmaTimes","summary":"invoX Pharma’s FS222 delivers encouraging solid tumour treatment results - PharmaTimes","headline":"invoX Pharma’s FS222 delivers encouraging solid tumour treatment results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOc3FDV0E2TmRLNHB1bzZKR0lMeFFnX054TVNValdqTElWc3F5RXM3N2xRY2xTcXZYLTFKaVlvOGxMdVFTUmI3dmZ3amhvQ25kQk1Yd2FZQVI3SU1xdXJZX0RVTGtqTmJKSTdZTnJpc2l0dGVzYnZMcEh5WjlTQnAzRW5TaUJDTEZWOVhWaGRQME1OY0VkWHEzUWEwYmdzd1NyVHFlTEZfLWxTZ2FYTVFYY3cwT0M0VW8?oc=5","date":"2024-04-24","type":"deal","source":"BioSpectrum Asia","summary":"invoX Pharma and Insilico Medicine partner to enhance R&D using AI - BioSpectrum Asia","headline":"invoX Pharma and Insilico Medicine partner to enhance R&D using AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNLVdYMGd4X3dIRnlheTQyY2dmc2hMTXdoYjZic1NIXzFUWWJiRF9NdGZlazRMdDB6dTljejcyVlZrTHM0eXZBQTZzRUdjME5SN0V5dFdEM3hHc2ZWY0hJbEcwQmFvcW01TjdzdVR6SjFOdFIxOFM1bmVxY1NVT3EtekxFVHNFWnhxSjhubnZwMA?oc=5","date":"2023-06-01","type":"pipeline","source":"Via Ritzau","summary":"INVOX-PHARMA-LIMITED - Via Ritzau","headline":"INVOX-PHARMA-LIMITED","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPd19jWHZYbDdRN3NBWDFsRlZlZ3Z2Y2hIanBUM1JZNlc2MlJrOFNadVc0SzQwWUZXWkh0R1l3SVl3SjJmT296WUNTMl96LVpyc1FaM3N4d3p1QVZUeUhSajJsdFZqZWh0LXR6aVNIX0ZWUTdKWGlyNXRDNWNlOXpRWGNXQm9FWl9wY3NaSnRiYWZPSTVpSFg1cF9jTE0xcHZSMFA4Qml3bk1tcXlZTjA1TzF0b2d2ZGM?oc=5","date":"2023-03-21","type":"pipeline","source":"Bdaily","summary":"Global pharmaceutical company moves into life sciences hub White City Place - Bdaily","headline":"Global pharmaceutical company moves into life sciences hub White City Place","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNeWV2MnZwM1JVR05DX005MlQ0NmZ3akZlWU1XOGJsVTRSNVRuMUJTR1dsd2xXS2h5cWFhNWdVamZxSlFyWmpVWFRtOXVQejlwTzl6dEMwSXZsWWVkNDQ2MmtUQTZRU0l0SzlRbUdtX1NsdXVvLU1WTFhlODhzaG8yTWdiZnY2SWN2OTlQU1RVN284dVlJNnBqSEoySWFTczNVdkkzazY4RmkycHRqMHhr?oc=5","date":"2023-03-16","type":"deal","source":"Cambridge Independent","summary":"F-star Therapeutics acquired by invoX Pharma for $161m - Cambridge Independent","headline":"F-star Therapeutics acquired by invoX Pharma for $161m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxQQ0ZiZXY4aTdzYVU4dGRsWWFXcXZ6TERyWWZPd3l1a1VFYWRwVDZnOXBaQzJxcF93NUpFVE5kSDBQV3BBVEhXYlFpM3ZxUFhseTBNTWV6VDJVdjJUdl9XemY3dHV4YTVUcWdDc3FfeGlRT2JDbGxTOHFlNzQyaWdSNVlULUZoNUNhdGlQSWFBSEw2V09qWENzX0ZoTWhJTVVoWmNEYVV6Y0VFVFJHR1JKMnZNTTdUWVVscDN1bnNkNW1mQXJfb2JIU2NFZTdzcjhtNVIzMHJqY3M2S1lhdVQzXzlXTWFRTF9WUlMwQzNsQTl2NGMtaUFhUjBfcmtsX0Q3VFFuSFlDNlFNeGw3TnBpUEMtYnc5OFI1N19rSF9YRDhreDZQZ3Rr?oc=5","date":"2022-06-23","type":"deal","source":"GlobeNewswire","summary":"invoX Pharma to Acquire F-star Therapeutics, Inc. a - GlobeNewswire","headline":"invoX Pharma to Acquire F-star Therapeutics, Inc. a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNQVVnbTZRNmxyNDRqaWRYYzZqOHNYb2g2RS1xT2RxaUZ3bk5KanYwSjg5NkpCX0ZBVVI0eFdvTnRQRjd2R0hGNDFGUnQtczJUT0xNSmRobENFeTh6SHhnQ0RuV0thVW1tT3dwWHpoTVV2cUJKdExaaG5aZGhkdFBNX0ZHb2d1TGZvMnc?oc=5","date":"2022-06-23","type":"deal","source":"citybiz","summary":"invoX Pharma to Acquire F-star Therapeutics - citybiz","headline":"invoX Pharma to Acquire F-star Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQa2ppeDltZzgyV3VpSURLejltbHZSdGdGS1gzMkk1TDAtamZjYzB4alpWa01WUTQ3MmhRaWctLWNGOTc5SllwREx6OVNlTTQ1SXcyeDNqNENRVF9GZnQ4RVJvc3NBX05FMkJPblNySmtqX3V1MnY4dWYzelRhZWt5ejVmTE1iOXA5SVE4T19CUFNmUQ?oc=5","date":"2022-06-23","type":"deal","source":"The Pharma Letter","summary":"invoX Pharma to acquire F-star Therapeutics - The Pharma Letter","headline":"invoX Pharma to acquire F-star Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}